Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 32 Breast Neoplasms 18 Neoplasms 9 Triple Negative Breast Neoplasms 8 Neoplasm Metastasis 7 Sarcoma 6 Prostatic Neoplasms 6 Fanconi Anemia, Complementation Group D1 6 Pancreatic Neoplasms 5 Endometrial Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Recurrence 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Fallopian Tube Neoplasms 4 Colorectal Neoplasms 4 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Mesothelioma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1

Interventions

talazoparib 1 olaparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Saline Solution 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Ovarian Cancer × olaparib × Clear all

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡